nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.0209	0.139	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.00831	0.0554	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00773	0.0515	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.0066	0.0441	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00541	0.0361	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00456	0.0304	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00448	0.0299	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00384	0.0256	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00373	0.0249	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00368	0.0245	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.0034	0.0227	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00328	0.0219	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00326	0.0218	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00326	0.0217	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—CRP—ankylosing spondylitis	0.00299	0.0199	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00293	0.0195	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00291	0.0194	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00289	0.0193	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00279	0.0186	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00269	0.0179	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00267	0.0178	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00267	0.0178	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00248	0.0165	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00238	0.0158	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00228	0.0152	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00222	0.0148	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.00215	0.0143	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00213	0.0142	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00189	0.0126	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00174	0.0116	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00166	0.0111	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00165	0.011	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.0015	0.01	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—ankylosing spondylitis	0.00135	0.00903	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00125	0.00836	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.00124	0.00828	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.0012	0.00801	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00114	0.00759	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00109	0.00728	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.00108	0.00717	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00107	0.00713	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00107	0.00711	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.00102	0.00678	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000983	0.00656	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000967	0.00645	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000893	0.00596	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000887	0.00592	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00081	0.0054	CbGpPWpGaD
Octreotide—Malaise—Dexamethasone—ankylosing spondylitis	0.000798	0.000939	CcSEcCtD
Octreotide—Oedema—Triamcinolone—ankylosing spondylitis	0.000796	0.000936	CcSEcCtD
Octreotide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000796	0.000936	CcSEcCtD
Octreotide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000795	0.000935	CcSEcCtD
Octreotide—Vertigo—Betamethasone—ankylosing spondylitis	0.000795	0.000935	CcSEcCtD
Octreotide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000794	0.000934	CcSEcCtD
Octreotide—Syncope—Betamethasone—ankylosing spondylitis	0.000794	0.000934	CcSEcCtD
Octreotide—Syncope—Dexamethasone—ankylosing spondylitis	0.000794	0.000934	CcSEcCtD
Octreotide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000791	0.00093	CcSEcCtD
Octreotide—Infection—Triamcinolone—ankylosing spondylitis	0.000791	0.00093	CcSEcCtD
Octreotide—Infection—Methylprednisolone—ankylosing spondylitis	0.000789	0.000928	CcSEcCtD
Octreotide—Haematuria—Methotrexate—ankylosing spondylitis	0.000786	0.000924	CcSEcCtD
Octreotide—Shock—Triamcinolone—ankylosing spondylitis	0.000783	0.000921	CcSEcCtD
Octreotide—Insomnia—Prednisolone—ankylosing spondylitis	0.000783	0.000921	CcSEcCtD
Octreotide—Alopecia—Prednisone—ankylosing spondylitis	0.000782	0.00092	CcSEcCtD
Octreotide—Shock—Methylprednisolone—ankylosing spondylitis	0.000781	0.000919	CcSEcCtD
Octreotide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000779	0.000917	CcSEcCtD
Octreotide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000779	0.000916	CcSEcCtD
Octreotide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000778	0.000915	CcSEcCtD
Octreotide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000778	0.000915	CcSEcCtD
Octreotide—Epistaxis—Methotrexate—ankylosing spondylitis	0.000777	0.000914	CcSEcCtD
Octreotide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000777	0.000914	CcSEcCtD
Octreotide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000777	0.000914	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000777	0.00518	CbGpPWpGaD
Octreotide—Mental disorder—Prednisone—ankylosing spondylitis	0.000776	0.000912	CcSEcCtD
Octreotide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000775	0.000912	CcSEcCtD
Octreotide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000771	0.000907	CcSEcCtD
Octreotide—Erythema—Prednisone—ankylosing spondylitis	0.000771	0.000907	CcSEcCtD
Octreotide—Malnutrition—Prednisone—ankylosing spondylitis	0.000771	0.000907	CcSEcCtD
Octreotide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000769	0.000905	CcSEcCtD
Octreotide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000768	0.000903	CcSEcCtD
Octreotide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000767	0.000902	CcSEcCtD
Octreotide—Convulsion—Betamethasone—ankylosing spondylitis	0.000767	0.000902	CcSEcCtD
Octreotide—Hypertension—Betamethasone—ankylosing spondylitis	0.000764	0.000899	CcSEcCtD
Octreotide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000764	0.000899	CcSEcCtD
Octreotide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000753	0.000886	CcSEcCtD
Octreotide—Myalgia—Betamethasone—ankylosing spondylitis	0.000753	0.000886	CcSEcCtD
Octreotide—Anxiety—Dexamethasone—ankylosing spondylitis	0.000751	0.000883	CcSEcCtD
Octreotide—Anxiety—Betamethasone—ankylosing spondylitis	0.000751	0.000883	CcSEcCtD
Octreotide—Discomfort—Betamethasone—ankylosing spondylitis	0.000744	0.000876	CcSEcCtD
Octreotide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000744	0.000876	CcSEcCtD
Octreotide—Pain—Prednisolone—ankylosing spondylitis	0.00074	0.000871	CcSEcCtD
Octreotide—Hepatitis—Methotrexate—ankylosing spondylitis	0.00074	0.00087	CcSEcCtD
Octreotide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000734	0.000864	CcSEcCtD
Octreotide—Vision blurred—Prednisone—ankylosing spondylitis	0.000726	0.000854	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000725	0.000853	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000724	0.000851	CcSEcCtD
Octreotide—Oedema—Dexamethasone—ankylosing spondylitis	0.000722	0.00085	CcSEcCtD
Octreotide—Oedema—Betamethasone—ankylosing spondylitis	0.000722	0.00085	CcSEcCtD
Octreotide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000722	0.00085	CcSEcCtD
Octreotide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000722	0.00085	CcSEcCtD
Octreotide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00072	0.000847	CcSEcCtD
Octreotide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000718	0.000845	CcSEcCtD
Octreotide—Infection—Betamethasone—ankylosing spondylitis	0.000717	0.000844	CcSEcCtD
Octreotide—Infection—Dexamethasone—ankylosing spondylitis	0.000717	0.000844	CcSEcCtD
Octreotide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000715	0.000841	CcSEcCtD
Octreotide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000715	0.000841	CcSEcCtD
Octreotide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000713	0.000839	CcSEcCtD
Octreotide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000713	0.000839	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000713	0.000839	CcSEcCtD
Octreotide—Anaemia—Prednisone—ankylosing spondylitis	0.000712	0.000838	CcSEcCtD
Octreotide—Shock—Dexamethasone—ankylosing spondylitis	0.000711	0.000836	CcSEcCtD
Octreotide—Shock—Betamethasone—ankylosing spondylitis	0.000711	0.000836	CcSEcCtD
Octreotide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00071	0.000835	CcSEcCtD
Octreotide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000708	0.000833	CcSEcCtD
Octreotide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000708	0.000833	CcSEcCtD
Octreotide—Agitation—Prednisone—ankylosing spondylitis	0.000708	0.000833	CcSEcCtD
Octreotide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000707	0.000832	CcSEcCtD
Octreotide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000707	0.000832	CcSEcCtD
Octreotide—Tachycardia—Betamethasone—ankylosing spondylitis	0.000705	0.000829	CcSEcCtD
Octreotide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000705	0.000829	CcSEcCtD
Octreotide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000701	0.000824	CcSEcCtD
Octreotide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000699	0.000822	CcSEcCtD
Octreotide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000698	0.000821	CcSEcCtD
Octreotide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000698	0.000821	CcSEcCtD
Octreotide—Malaise—Prednisone—ankylosing spondylitis	0.000695	0.000818	CcSEcCtD
Octreotide—Vertigo—Prednisone—ankylosing spondylitis	0.000692	0.000814	CcSEcCtD
Octreotide—Syncope—Prednisone—ankylosing spondylitis	0.000691	0.000813	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00069	0.000811	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000689	0.00459	CbGpPWpGaD
Octreotide—Anorexia—Betamethasone—ankylosing spondylitis	0.000688	0.00081	CcSEcCtD
Octreotide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000688	0.00081	CcSEcCtD
Octreotide—Urticaria—Prednisolone—ankylosing spondylitis	0.000688	0.000809	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000687	0.000808	CcSEcCtD
Octreotide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000686	0.000807	CcSEcCtD
Octreotide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000685	0.000805	CcSEcCtD
Octreotide—Pain—Triamcinolone—ankylosing spondylitis	0.000681	0.000801	CcSEcCtD
Octreotide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000677	0.000797	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000672	0.00448	CbGpPWpGaD
Octreotide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000668	0.000786	CcSEcCtD
Octreotide—Convulsion—Prednisone—ankylosing spondylitis	0.000668	0.000785	CcSEcCtD
Octreotide—Hypertension—Prednisone—ankylosing spondylitis	0.000665	0.000783	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000658	0.000774	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000658	0.000774	CcSEcCtD
Octreotide—Arthralgia—Prednisone—ankylosing spondylitis	0.000656	0.000772	CcSEcCtD
Octreotide—Myalgia—Prednisone—ankylosing spondylitis	0.000656	0.000772	CcSEcCtD
Octreotide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000656	0.000772	CcSEcCtD
Octreotide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000654	0.00077	CcSEcCtD
Octreotide—Anxiety—Prednisone—ankylosing spondylitis	0.000654	0.000769	CcSEcCtD
Octreotide—Alopecia—Methotrexate—ankylosing spondylitis	0.000654	0.000769	CcSEcCtD
Octreotide—Insomnia—Betamethasone—ankylosing spondylitis	0.000653	0.000768	CcSEcCtD
Octreotide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000653	0.000768	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000652	0.000766	CcSEcCtD
Octreotide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000649	0.000764	CcSEcCtD
Octreotide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000649	0.000763	CcSEcCtD
Octreotide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000649	0.000763	CcSEcCtD
Octreotide—Discomfort—Prednisone—ankylosing spondylitis	0.000648	0.000763	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000648	0.000762	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000644	0.0043	CbGpPWpGaD
Octreotide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000644	0.000758	CcSEcCtD
Octreotide—Erythema—Methotrexate—ankylosing spondylitis	0.000644	0.000758	CcSEcCtD
Octreotide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000638	0.00075	CcSEcCtD
Octreotide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000636	0.000748	CcSEcCtD
Octreotide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000636	0.000748	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000636	0.00424	CbGpPWpGaD
Octreotide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000632	0.000744	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MMP3—ankylosing spondylitis	0.000631	0.00421	CbGpPWpGaD
Octreotide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000631	0.000742	CcSEcCtD
Octreotide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000629	0.00074	CcSEcCtD
Octreotide—Oedema—Prednisone—ankylosing spondylitis	0.000629	0.00074	CcSEcCtD
Octreotide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000629	0.00074	CcSEcCtD
Octreotide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000628	0.000739	CcSEcCtD
Octreotide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000628	0.000739	CcSEcCtD
Octreotide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000628	0.000739	CcSEcCtD
Octreotide—Infection—Prednisone—ankylosing spondylitis	0.000625	0.000735	CcSEcCtD
Octreotide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000624	0.000733	CcSEcCtD
Octreotide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000624	0.000733	CcSEcCtD
Octreotide—Back pain—Methotrexate—ankylosing spondylitis	0.000623	0.000733	CcSEcCtD
Octreotide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000623	0.000732	CcSEcCtD
Octreotide—Fatigue—Betamethasone—ankylosing spondylitis	0.000623	0.000732	CcSEcCtD
Octreotide—Shock—Prednisone—ankylosing spondylitis	0.000619	0.000728	CcSEcCtD
Octreotide—Pain—Betamethasone—ankylosing spondylitis	0.000618	0.000727	CcSEcCtD
Octreotide—Pain—Dexamethasone—ankylosing spondylitis	0.000618	0.000727	CcSEcCtD
Octreotide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000617	0.000726	CcSEcCtD
Octreotide—Tachycardia—Prednisone—ankylosing spondylitis	0.000614	0.000722	CcSEcCtD
Octreotide—Skin disorder—Prednisone—ankylosing spondylitis	0.000611	0.000719	CcSEcCtD
Octreotide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000608	0.000715	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000607	0.000714	CcSEcCtD
Octreotide—Anorexia—Prednisone—ankylosing spondylitis	0.0006	0.000705	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000598	0.000703	CcSEcCtD
Octreotide—Anaemia—Methotrexate—ankylosing spondylitis	0.000595	0.0007	CcSEcCtD
Octreotide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000595	0.0007	CcSEcCtD
Octreotide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000595	0.0007	CcSEcCtD
Octreotide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000591	0.000695	CcSEcCtD
Octreotide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000591	0.000695	CcSEcCtD
Octreotide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000586	0.00069	CcSEcCtD
Octreotide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000585	0.000688	CcSEcCtD
Octreotide—Malaise—Methotrexate—ankylosing spondylitis	0.000581	0.000683	CcSEcCtD
Octreotide—Vertigo—Methotrexate—ankylosing spondylitis	0.000579	0.000681	CcSEcCtD
Octreotide—Urticaria—Betamethasone—ankylosing spondylitis	0.000574	0.000675	CcSEcCtD
Octreotide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000574	0.000675	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000573	0.000674	CcSEcCtD
Octreotide—Dizziness—Prednisolone—ankylosing spondylitis	0.000572	0.000673	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000572	0.00381	CbGpPWpGaD
Octreotide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000571	0.000672	CcSEcCtD
Octreotide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000571	0.000672	CcSEcCtD
Octreotide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000571	0.000672	CcSEcCtD
Octreotide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000571	0.000672	CcSEcCtD
Octreotide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000571	0.000672	CcSEcCtD
Octreotide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00057	0.00067	CcSEcCtD
Octreotide—Insomnia—Prednisone—ankylosing spondylitis	0.000569	0.000669	CcSEcCtD
Octreotide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000565	0.000664	CcSEcCtD
Octreotide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000563	0.000662	CcSEcCtD
Octreotide—Cough—Methotrexate—ankylosing spondylitis	0.000562	0.000661	CcSEcCtD
Octreotide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000562	0.000661	CcSEcCtD
Octreotide—Convulsion—Methotrexate—ankylosing spondylitis	0.000558	0.000656	CcSEcCtD
Octreotide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000554	0.000651	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000548	0.000645	CcSEcCtD
Octreotide—Chest pain—Methotrexate—ankylosing spondylitis	0.000548	0.000645	CcSEcCtD
Octreotide—Myalgia—Methotrexate—ankylosing spondylitis	0.000548	0.000645	CcSEcCtD
Octreotide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000547	0.000643	CcSEcCtD
Octreotide—Rash—Prednisolone—ankylosing spondylitis	0.000546	0.000642	CcSEcCtD
Octreotide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000545	0.000641	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000545	0.000641	CcSEcCtD
Octreotide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000543	0.000639	CcSEcCtD
Octreotide—Fatigue—Prednisone—ankylosing spondylitis	0.000542	0.000638	CcSEcCtD
Octreotide—Headache—Prednisolone—ankylosing spondylitis	0.000542	0.000638	CcSEcCtD
Octreotide—Discomfort—Methotrexate—ankylosing spondylitis	0.000542	0.000637	CcSEcCtD
Octreotide—Constipation—Prednisone—ankylosing spondylitis	0.000538	0.000633	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000527	0.00352	CbGpPWpGaD
Octreotide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000526	0.000619	CcSEcCtD
Octreotide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000526	0.000618	CcSEcCtD
Octreotide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000525	0.000618	CcSEcCtD
Octreotide—Infection—Methotrexate—ankylosing spondylitis	0.000522	0.000614	CcSEcCtD
Octreotide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000518	0.00061	CcSEcCtD
Octreotide—Asthenia—Betamethasone—ankylosing spondylitis	0.000518	0.00061	CcSEcCtD
Octreotide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000518	0.00061	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000515	0.000606	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000515	0.000605	CcSEcCtD
Octreotide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000514	0.000605	CcSEcCtD
Octreotide—Nausea—Prednisolone—ankylosing spondylitis	0.000514	0.000605	CcSEcCtD
Octreotide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000511	0.000601	CcSEcCtD
Octreotide—Pruritus—Betamethasone—ankylosing spondylitis	0.000511	0.000601	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000511	0.000601	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000508	0.000598	CcSEcCtD
Octreotide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000506	0.000595	CcSEcCtD
Octreotide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000505	0.000594	CcSEcCtD
Octreotide—Rash—Triamcinolone—ankylosing spondylitis	0.000502	0.00059	CcSEcCtD
Octreotide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000501	0.00059	CcSEcCtD
Octreotide—Anorexia—Methotrexate—ankylosing spondylitis	0.000501	0.000589	CcSEcCtD
Octreotide—Rash—Methylprednisolone—ankylosing spondylitis	0.000501	0.000589	CcSEcCtD
Octreotide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0005	0.000589	CcSEcCtD
Octreotide—Urticaria—Prednisone—ankylosing spondylitis	0.0005	0.000588	CcSEcCtD
Octreotide—Headache—Triamcinolone—ankylosing spondylitis	0.000499	0.000587	CcSEcCtD
Octreotide—Headache—Methylprednisolone—ankylosing spondylitis	0.000498	0.000585	CcSEcCtD
Octreotide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000497	0.000585	CcSEcCtD
Octreotide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000497	0.000585	CcSEcCtD
Octreotide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000494	0.000581	CcSEcCtD
Octreotide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000494	0.000581	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000479	0.000563	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000479	0.00319	CbGpPWpGaD
Octreotide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000478	0.000562	CcSEcCtD
Octreotide—Dizziness—Betamethasone—ankylosing spondylitis	0.000478	0.000562	CcSEcCtD
Octreotide—Insomnia—Methotrexate—ankylosing spondylitis	0.000475	0.000559	CcSEcCtD
Octreotide—Nausea—Triamcinolone—ankylosing spondylitis	0.000473	0.000556	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000472	0.000555	CcSEcCtD
Octreotide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000472	0.000555	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000469	0.000551	CcSEcCtD
Octreotide—Somnolence—Methotrexate—ankylosing spondylitis	0.000467	0.00055	CcSEcCtD
Octreotide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000463	0.000545	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000463	0.000544	CcSEcCtD
Octreotide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000459	0.00054	CcSEcCtD
Octreotide—Vomiting—Betamethasone—ankylosing spondylitis	0.000459	0.00054	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000459	0.00306	CbGpPWpGaD
Octreotide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000457	0.000538	CcSEcCtD
Octreotide—Rash—Dexamethasone—ankylosing spondylitis	0.000455	0.000536	CcSEcCtD
Octreotide—Rash—Betamethasone—ankylosing spondylitis	0.000455	0.000536	CcSEcCtD
Octreotide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000455	0.000535	CcSEcCtD
Octreotide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000455	0.000535	CcSEcCtD
Octreotide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000454	0.000534	CcSEcCtD
Octreotide—Fatigue—Methotrexate—ankylosing spondylitis	0.000453	0.000533	CcSEcCtD
Octreotide—Headache—Betamethasone—ankylosing spondylitis	0.000452	0.000532	CcSEcCtD
Octreotide—Headache—Dexamethasone—ankylosing spondylitis	0.000452	0.000532	CcSEcCtD
Octreotide—Asthenia—Prednisone—ankylosing spondylitis	0.000451	0.000531	CcSEcCtD
Octreotide—Pain—Methotrexate—ankylosing spondylitis	0.000449	0.000529	CcSEcCtD
Octreotide—Pruritus—Prednisone—ankylosing spondylitis	0.000445	0.000523	CcSEcCtD
Octreotide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000433	0.00051	CcSEcCtD
Octreotide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00043	0.000506	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00043	0.000506	CcSEcCtD
Octreotide—Nausea—Betamethasone—ankylosing spondylitis	0.000429	0.000505	CcSEcCtD
Octreotide—Nausea—Dexamethasone—ankylosing spondylitis	0.000429	0.000505	CcSEcCtD
Octreotide—Urticaria—Methotrexate—ankylosing spondylitis	0.000418	0.000491	CcSEcCtD
Octreotide—Dizziness—Prednisone—ankylosing spondylitis	0.000416	0.000489	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000416	0.000489	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000416	0.000489	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—MMP3—ankylosing spondylitis	0.000407	0.00271	CbGpPWpGaD
Octreotide—Vomiting—Prednisone—ankylosing spondylitis	0.0004	0.00047	CcSEcCtD
Octreotide—Rash—Prednisone—ankylosing spondylitis	0.000397	0.000467	CcSEcCtD
Octreotide—Dermatitis—Prednisone—ankylosing spondylitis	0.000396	0.000466	CcSEcCtD
Octreotide—Headache—Prednisone—ankylosing spondylitis	0.000394	0.000464	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000387	0.000456	CcSEcCtD
Octreotide—Asthenia—Methotrexate—ankylosing spondylitis	0.000377	0.000444	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000376	0.0025	CbGpPWpGaD
Octreotide—Nausea—Prednisone—ankylosing spondylitis	0.000374	0.000439	CcSEcCtD
Octreotide—Pruritus—Methotrexate—ankylosing spondylitis	0.000372	0.000437	CcSEcCtD
Octreotide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00036	0.000423	CcSEcCtD
Octreotide—Dizziness—Methotrexate—ankylosing spondylitis	0.000348	0.000409	CcSEcCtD
Octreotide—Vomiting—Methotrexate—ankylosing spondylitis	0.000334	0.000393	CcSEcCtD
Octreotide—Rash—Methotrexate—ankylosing spondylitis	0.000331	0.00039	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000331	0.00039	CcSEcCtD
Octreotide—Headache—Methotrexate—ankylosing spondylitis	0.000329	0.000387	CcSEcCtD
Octreotide—Nausea—Methotrexate—ankylosing spondylitis	0.000312	0.000367	CcSEcCtD
